Comments
Commented by André Will-Laudien on September 15th, 2021 | 14:23 CEST
Nel ASA, Enapter, Plug Power, FuelCell Energy - It is time to go all out!
Hydrogen is not only a climate-friendly means of propulsion for automobiles and heavy-duty transport. Large industries such as chemicals and steel can use hydrogen technology to reduce their consumption of natural gas. There are costs involved when converting to hydrogen, most of which are only feasible with political support. The German government's national hydrogen strategy fits in well here. But medium-sized industries, especially energy-intensive sectors, could also become much more environmentally friendly with hydrogen-based technologies. Which stocks are well-positioned here?
Read
Commented by Armin Schulz on September 15th, 2021 | 14:03 CEST
JinkoSolar, Defense Metals, Daimler - Sustainability only with rare earths
Rare earths are found in almost all new technologies such as smartphones, e-cars, etc. The leading supplier is China. Rare earths occur more often than one might think, but mining them is rarely economically profitable. Thus, China has a kind of monopoly position. With the trade dispute between the US and China brewing, more people realize that Western countries should seek alternative access to rare earths. If China limits exports, it would quickly lead to shortages. Accumulators or batteries would soon become scarce. Due to sustainability issues, the increased demand can already be seen in the increased prices for rare earths.
Read
Commented by Stefan Feulner on September 15th, 2021 | 13:04 CEST
Steinhoff, Sierra Grande Minerals, Barrick Gold - Played into the cards
The latest inflation data in the world's largest economy, the USA, plays into the central bank's strategy cards. After 5.4% in the previous month, the inflation rate weakened moderately to 5.3% in August, breaking the trend that had been rising for months for the first time. The FED, which sees the hype in the inflation curve as temporary due to the recovery after the Corona Crisis, thus feels vindicated and continues its ultra-loose monetary policy with bond purchases of USD 120 billion per month in favor of growth.
Read
Commented by André Will-Laudien on September 15th, 2021 | 12:51 CEST
Bayer, Water Ways Technologies, Kali & Salz - Clean water for 7.9 billion!
Clean water, good nutrition and hygiene are basic human needs and indispensable for healthy development. For this reason, as part of the Sustainable Development Goals, the world's countries have set themselves the goal of giving everyone access to clean drinking water and adequate sanitation by 2030. These are two issues that need to be addressed, particularly in areas of the world that are difficult to access or inhospitable. Africa and Asia are at the forefront of the need here; they hope for few standards taken for granted in the developed world. We look at some interesting shares from this area.
Read
Commented by Nico Popp on September 15th, 2021 | 12:17 CEST
Valneva, Cardiol Therapeutics, Sartorius: Healthy returns in every market phase
The pandemic has given the healthcare sector a boost. If people were still somewhat hesitant to talk about the digitization of the healthcare system in 2019, the epidemic has clearly revealed where the weaknesses are. New drugs and procedures could also be tested under the new framework conditions. If nothing else, the industry is getting renewed attention as a result. We outline three companies and explain whether the shares have prospects or not.
Read
Commented by Carsten Mainitz on September 15th, 2021 | 11:23 CEST
AdTiger, ProSiebenSat.1, SAP - Digital winners
The digital transformation of the global economy is in full swing. Fast Internet connections, smartphones, apps and cloud solutions are spurring the growth of digital and scalable business models. At the same time, the success stories of digitalization are multifaceted. These exciting investments are not to be missed.
Read
Commented by Nico Popp on September 15th, 2021 | 10:39 CEST
Deutsche Bank, BIGG Digital Assets, Commerzbank: Let the money work for you
Anyone who wants to make a good cut financially gets involved wherever as much money as possible is turned over. Decades ago, the good old "bank apprenticeship" was considered a solid foundation for the future. Although the young bankers of the time have become better real estate agents in recent years, the principle remains the same: Where money is turned over, there is also something to be gained. It is much the same for investors.
Read
Commented by Nico Popp on September 14th, 2021 | 13:10 CEST
BioNTech, Defence Therapeutics, Valneva: Here, the overall market (almost) does not matter
Is the crash coming or not? Meanwhile, even Wall Street banks are warning of an imminent crash event. Many commentators are jumping on the bandwagon. The reasons: Delta variation, supply problems and inflation, and an economy that could suffer. But if you compare the crashes of the past years, one thing becomes clear: Only the fewest price setbacks came with notice! We present three stocks that many investors believe can combine growth and security.
Read
Commented by Stefan Feulner on September 14th, 2021 | 13:07 CEST
Nvidia, BrainChip Holdings, Palantir - To the moon
According to high-ranking managers of the largest chip manufacturers such as Intel and Nvidia, the end of the semiconductor crisis is not in sight before the end of 2022. Besides the increasing demand for consumer electronics, computers and accessories since the beginning of the Corona Crisis, the industry is also being hit by the strong growth in demand from the automotive industry, which is increasingly relying on electronics. Artificial intelligence, 5G and the Internet of Things will further fuel demand in the coming years.
Read
Commented by Fabian Lorenz on September 14th, 2021 | 12:02 CEST
MorphoSys, HelloFresh, Aspermont - Price halving or rebound?
Investors are likely to speculate on a rebound in the Valneva share in the coming days; because the price slide of over 30% on Monday was violent. Stifel analysts see sales and earnings estimates for 2020 and 2021 in jeopardy after the UK government unexpectedly canceled a major order for the COVID-19 vaccine under development. Investors have been waiting for a rebound in MorphoSys shares for some time. The latest analyst assessment gives little hope. If Bernstein Research has its way, HelloFresh could soon be down almost 50%. Aspermont seems ripe for a rebound - the share is interesting from a chart perspective, and analysts advise buying.
Read